We're being asked to play God in deciding who gets the vaccine
In the autumn of 2020, Ireland's public health system confronted a paradox of its own good intentions: a citizenry newly awakened to the value of vaccination, and a supply chain unable to meet the moment. General practitioners across the country were left to decide, patient by patient, who would receive protection against influenza and who would not — a burden that belongs to no single doctor, but to the systems and structures that shape what care is possible. The shortage revealed not a failure of effort, but the fragility of preparedness when global demand outpaces the finite rhythms of pharmaceutical production.
- Irish GPs are being forced into triage decisions that pit pregnant women against elderly patients and the chronically ill against one another, with no good answer available.
- The HSE nearly doubled its vaccine order from the previous year, yet still found itself with only half its doses delivered by late October and no further restocking on the horizon.
- Each GP practice will receive just a quarter of its previous season's allocation in the final delivery window, leaving waiting lists of hundreds with no realistic prospect of vaccination.
- A troubling equity gap has emerged: private pharmacies appear to hold adequate stock for paying customers while the public health system rations doses for its most vulnerable patients.
- The HSE frames record demand as a public health success, but for the thousands of high-risk patients turned away this winter, awareness without access offers little comfort.
In late October 2020, Irish GPs found themselves in an ethically impossible position — deciding which patients would receive a flu vaccine and which would not. One Cork doctor, speaking anonymously, captured the weight of it plainly: the HSE had informed practices that one final delivery was coming, and after that, nothing more for the year.
The shortage arose from a collision of forces. Covid-19 had driven flu vaccination demand to unprecedented levels across Ireland and globally, while manufacturers could only produce so much. The HSE had attempted to get ahead of the crisis by purchasing nearly two million doses — almost double the previous season — but even that aggressive effort proved insufficient once the public mobilised in record numbers.
By late October, 950,000 doses had been distributed nationally. The final delivery cycle, running from October 29th to November 11th, would give each GP practice just twenty-five percent of what they had used the season before. For one Cork practice, that meant forty additional vaccines while 190 patients waited with no prospect of being seen.
The HSE's priority framework, drawn from WHO guidance, placed those aged sixty-five and over and healthcare workers at the top. Pregnant women and people with chronic conditions fell into a second tier — meaning a sixty-year-old with diabetes, hypertension, and heart disease could be turned away. The Cork doctor also questioned why teachers, Special Needs Assistants, and gardaí had been excluded from the priority list entirely.
Perhaps the sharpest question was one the HSE could not answer: why did private pharmacies appear to have adequate supplies while the public system rationed doses? The agency noted it had not procured or distributed private stock, and left the discrepancy unexplained. Record demand, the HSE offered, was a sign that public awareness had improved. But for the vulnerable patients facing winter without protection, awareness without access is a hollow kind of progress.
In late October 2020, Irish general practitioners found themselves in an ethically impossible position: deciding which of their patients would receive a flu vaccine and which would not. A Cork doctor, speaking anonymously to protect his practice, described the situation with blunt frustration. "We're just playing catch up and now we're being asked to play God in terms of who should get a vaccine and who should not," he said. The HSE had informed all GPs that one final delivery of flu vaccine was coming, and after that, there would be nothing more for the remainder of the year.
The shortage had emerged from a collision of circumstances. Demand for flu vaccination had reached unprecedented levels both in Ireland and globally, driven partly by heightened awareness during the Covid-19 pandemic. At the same time, manufacturers could only produce a finite supply. The HSE had attempted to prepare by purchasing nearly two million doses—almost double what had been administered the previous season—but even this aggressive stockpiling proved insufficient once the public began seeking protection in record numbers.
By October 28th, the national cold chain service had distributed 950,000 doses across the country, a ten percent increase compared to the same point the year before. The fourth and final delivery cycle would arrive between October 29th and November 11th, but each GP would receive only twenty-five percent of what they had used in the previous season. For one Cork practice, this meant receiving forty additional vaccines after having already distributed thirty the day before, while 190 patients sat on a waiting list with no prospect of being vaccinated.
The HSE had established a priority framework based on World Health Organisation guidance. The highest priority group included people aged sixty-five and older, healthcare workers, and home care workers with direct patient contact. Pregnant women, despite their vulnerability, fell into a second tier called Additional Risk Groups, alongside people with underlying health conditions and other healthcare workers. This categorization created the impossible choices that haunted GPs. A sixty-year-old patient with diabetes, hypertension, and a history of heart disease would have to be turned away. Pregnant women would hear "maybe not" when they called seeking protection.
The Cork doctor questioned the logic of the entire situation. Teachers, Special Needs Assistants, and gardaí—all working with vulnerable populations—had not been included on the priority list, yet he believed they should have been. He also raised a question that cut to the heart of the equity problem: private pharmacies appeared to have adequate supplies for those willing to pay, while the public health system faced rationing. The HSE responded that it had not procured or distributed private stock and therefore could not explain the discrepancy.
The HSE defended its purchasing decisions, noting that the 1.4 million adult doses of Quadrivalent Influenza Vaccine represented a twenty percent increase over the previous season and reflected expected uptake in targeted groups. The unprecedented demand, the agency said, was actually a positive sign—evidence that public awareness of vaccination had improved. But awareness without access is a hollow victory. As flu season deepened and cases climbed, thousands of vulnerable Irish patients would face the winter without the protection they had sought, their GPs left to make rationing decisions that no doctor should have to make.
Citas Notables
We're just playing catch up and now we're being asked to play God in terms of who should get a vaccine and who should not.— Anonymous Cork GP
There has been unprecedented demand for influenza vaccine this season, which is a positive reflection of public awareness.— HSE statement
La Conversación del Hearth Otra perspectiva de la historia
Why did demand spike so dramatically this year?
The pandemic changed how people thought about respiratory illness. People who might have skipped a flu shot before suddenly wanted protection. That awareness is good, but it exposed how fragile the supply chain actually is.
The HSE bought nearly double what they used last year. How is that not enough?
Because "nearly double" still wasn't enough to meet what turned out to be truly unprecedented demand. They made a reasonable forecast based on history, but history didn't prepare them for this moment.
Why are pregnant women not in the top priority group?
That's the question that haunted the doctors. Pregnant women are objectively vulnerable—they have weaker immune systems during pregnancy. But the WHO framework put them second, behind the elderly and healthcare workers. When supplies run out, second place means no vaccine.
The doctor mentioned private pharmacies had stock. What does that tell us?
It suggests the shortage wasn't absolute—it was a public system problem. Private suppliers could charge more, so they had incentive to secure stock. The public system couldn't compete on price, so it rationed instead.
What happens to the patients who don't get vaccinated?
They face the flu season unprotected. Some will get sick. Some will have complications. The elderly and chronically ill are most at risk of serious illness or death. That's the weight of these triage decisions.
Could this have been prevented?
Maybe. Better forecasting, earlier procurement, or different priority frameworks might have helped. But ultimately, you can't manufacture vaccines faster than factories can produce them. The real failure was not anticipating how much demand would outpace supply.